FDA commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss President Donald Trump's efforts to reduce drug ...

Millions face Medicare decisions each year, but many don’t take advantage of tools that can save them money and stress. Insurance marketing often overshadows unbiased options like SHIP, leaving people ...

Florida residents share their perspectives on Medicare enrollment, electric bicycle legislation, and education. Writers also express opinions on former President Trump, the measles vaccine, and ...

President Donald Trump has promised to stop taxing Social Security benefits, pitching the idea as a sweeping break for ...

While Social Security benefits are getting a decent raise in 2026, many seniors won't see all of it. An increase in Medicare ...

Millions of Americans using one of the Medicare programs may be leaving billions of dollars worth of benefits unused— ...

Last week, it was announced that the cost of Medicare premiums would increase by 9.7% in 2026 for 67.6 million beneficiaries — 949,495 of whom live in Louisiana.

Congress beefed up federal dollars to expand access to health care services in rural communities in the health and tax law signed in July by President Trump. The Rural Health Transformation program ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

Financial supporters for this research include Lipitz Center at Johns Hopkins University, United States, NIH National Institute on Aging. For more information on this research see: Algorithmic ...

Novo Nordisk A/S (NVO), though cheap at 13x forward earnings, is in my view a value trap, as growth is slowing and GLP-1 ...